Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. Report issue

Government Phase 1 Phase 3

Organization Overview

First Clinical Trial
2018
NCT03745885
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.